NDC 16729-366-45 - OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 16729-366
- Requested NDC
- 16729-366-45
- Package NDCs from labels
- 16729-366-10, 16729-366-15, 16729-366-16, 16729-366-17, 16729-366-45, 16729-366-46
- Manufacturer
- Accord Healthcare Inc. | Intas Pharmaceuticals Limited
- Effective date
- 2025-10-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LACTOSE MONOHYDRATE - Accord Healthcare Inc. | Intas Pharmaceuticals Limited | Accord Healthcare Inc. | Intas Pharmaceuticals Limited | 2025-10-29 | HUMAN PRESCRIPTION DRUG LABEL |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE - A-S Medication Solutions | A-S Medication Solutions | 2023-07-03 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16729-366-10 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 7 | |
| 16729-366-15 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 7 | |
| 16729-366-16 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 7 | |
| 16729-366-17 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 1000 in 1 BOTTLE | TABLET, FILM COATED | 1000 | 7 | |
| 16729-366-45 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 10 in 1 BLISTER PACK | TABLET, FILM COATED | 10 | 7 | |
| 16729-366-46 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 100 in 1 CARTON | TABLET, FILM COATED | 100 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16729-366-10 | EA - Each | 16729-366 | 39fc2de8-f862-4a2d-a12c-bfab23d6c60e | 1 | 2020-09-14 |
| 16729-366-15 | EA - Each | 16729-366 | 3400d9ab-caf6-4425-9c27-24a6d36b5abb | 1 | 2020-09-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| RODAN and FIELDS ENHANCEMENTS MEDIUM | TITANIUM DIOXIDE, ZINC OXIDE | Bentley Laboratories, LLC | 6aa6ad3f-2c52-4031-9e6c-7526c42de71d | 2026-01-09 | Warnings | 15FIX9V2JP |
| Lawn and Garden Detox 6026 | LAWN AND GARDEN DETOX | Professional Complementary Health Formulas | 2db4bdd8-1049-450a-8642-0e1dbbe5abb3 | 2026-01-08 | Warnings | 15FIX9V2JP |
| First Chakra (Root) 7301 | FIRST CHAKRA (ROOT) | Professional Complementary Health Formulas | 61eb1bbe-6675-4369-b852-18975e6b08c7 | 2026-01-08 | Warnings | 1K09F3G675 |
| BADABOOM SUNSCREEN | SUNSCREEN | Aopline Biotechnology (Guangzhou) Co., Ltd. | 47dbf363-2892-4530-e063-6294a90abe1f | 2026-01-08 | Warnings | 15FIX9V2JP |
| ROE WELLNESS SPF 50 MINERAL | SPF 50 MINERAL POWDER | Aopline Biotechnology (Guangzhou) Co., Ltd. | 47dc8155-4abb-4bb7-e063-6294a90af1ad | 2026-01-08 | Warnings | 15FIX9V2JP |
| ALOHA MINERAL BLOCK-BRUSH ON MINERAL | SUNSCREEN SPF50 | Aopline Biotechnology (Guangzhou) Co., Ltd. | 47dd07aa-71b4-5d54-e063-6394a90a4127 | 2026-01-08 | Warnings | 15FIX9V2JP |
| Anhydrous SPF 30 | TITANIUM DIOXIDE, ZINC OXIDE | Owen Biosciences, Inc. | 0cc8221d-5ec5-4abf-a4f5-ab06e8dcea68 | 2026-01-08 | Warnings | 15FIX9V2JP |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | AvPAK | ef56450d-86d3-2654-e053-2995a90a142c | 2026-01-08 | Warnings, Adverse reactions | 0J48LPH2TH |
| HM-B (EDIBLE VINEGAR) | TITANIUM OXIDE | DEMAND SERVICE, CO., LTD. | 9a7b1e74-b8af-449c-e053-2995a90a349e | 2026-01-08 | Warnings | 15FIX9V2JP |
| Third Chakra (Solar Plexus) 7303 | THIRD CHAKRA (SOLAR PLEXUS) | Professional Complementary Health Formulas | eea89c37-ab87-4cc7-8dfc-e7f42a580dd9 | 2026-01-08 | Warnings | 1K09F3G675 |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Advagen Pharma Ltd | a5525a2a-d2c7-411b-9ffc-0cc4fe77f7c7 | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hawaiian Blend Extreme Zinc SPF 30 | ZINC OXIDE, TITANIUM DIOXIDE | The Islander Group | 4084dd98-357f-4011-b0d4-db6536d2931f | 2026-01-07 | Warnings | 15FIX9V2JP |
| Hawaiian Blend Extreme Zinc SPF 50 | ZINC OXIDE, TITANIUM DIOXIDE | The Islander Group | 9b4acc5e-fdaf-4fcb-83a9-69e430dd43de | 2026-01-07 | Warnings | 15FIX9V2JP |
| Hawaiian Blend Sensitive Zinc SPF 50 | ZINC OXIDE, TITANIUM DIOXIDE | The Islander Group | b42261c5-fa6e-4bb3-93c0-97032ab9f716 | 2026-01-07 | Warnings | 15FIX9V2JP |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | 8808879d-8c7e-45d1-8a49-c05d2cf845d3 | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | 00f67e1a-6999-4295-9c9f-fcb1ce9711b8 | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | ec23c75d-68d5-46d0-be56-b96ddba19ed6 | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| BETA-GLUCAN MILD SUNSCREEN | TITANIUM DIOXIDE, ZINC OXIDE | IUNIK Co., Ltd | 47d6ad8b-1081-ee21-e063-6294a90a0e63 | 2026-01-07 | Warnings | 15FIX9V2JP |
| Solar Swipe Mineral Sunscreen SPF50 | SOLAR SWIPE MINERAL SUNSCREEN SPF50 | Guangzhou Fantesy Biotechnology Co.,Ltd | 47d75d61-5295-3eab-e063-6394a90a01c1 | 2026-01-07 | Warnings | 15FIX9V2JP |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Glenmark Pharmaceuticals Inc., USA | 1e55800d-f77c-4950-a6d7-2055f4c7ea17 | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.